{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:33:55Z","timestamp":1767652435472,"version":"3.37.3"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["CRSII5_180323"],"award-info":[{"award-number":["CRSII5_180323"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016964","name":"Werner Siemens Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016964","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejpb.2024.114507","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T06:09:46Z","timestamp":1726726186000},"page":"114507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Inhibition of influenza virus infection in mice by pulmonary administration of a spray dried antiviral drug"],"prefix":"10.1016","volume":"204","author":[{"given":"Rick","family":"Heida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo H.","family":"Jacob Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renate","family":"Akkerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Moser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"de Vries-Idema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lien","family":"Bornet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujeet","family":"Pawar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Stellacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henderik W.","family":"Frijlink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke L.W.","family":"Huckriede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter L.J.","family":"Hinrichs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2024.114507_b0005","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.chom.2022.11.016","article-title":"Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses","volume":"31","author":"Morens","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejpb.2024.114507_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.00039","article-title":"Influenza virus neuraminidase structure and functions","volume":"10","author":"McAuley","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejpb.2024.114507_b0015","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00040-22","article-title":"Antiviral Approaches against Influenza Virus","volume":"36","author":"Kumari","year":"2023","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejpb.2024.114507_b0020","doi-asserted-by":"crossref","first-page":"12244","DOI":"10.3390\/ijms232012244","article-title":"Evolution of influenza viruses\u2014drug resistance, treatment options, and prospects","volume":"23","author":"Smyk","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2024.114507_b0025","doi-asserted-by":"crossref","first-page":"2001012","DOI":"10.1002\/advs.202001012","article-title":"Non-toxic virucidal macromolecules show high efficacy against influenza virus ex vivo and in vivo","volume":"8","author":"Kocabiyik","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejpb.2024.114507_b0030","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3390\/pharmaceutics15020582","article-title":"Antiviral mechanism of virucidal sialic acid modified cyclodextrin","volume":"15","author":"Zhu","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2024.114507_b0035","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01295-23","article-title":"Inhalation of vaccines and antiviral drugs to fight respiratory virus infections: reasons to prioritize the pulmonary route of administration","volume":"14","author":"Heida","year":"2023","journal-title":"MBio"},{"key":"10.1016\/j.ejpb.2024.114507_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cocis.2021.101497","article-title":"Natural and bioinspired excipients for dry powder inhalation formulations","volume":"56","author":"Zillen","year":"2021","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.ejpb.2024.114507_b0045","doi-asserted-by":"crossref","first-page":"2023012","DOI":"10.14356\/kona.2023012","article-title":"Mechanistic formulation design of spray-dried powders","volume":"40","author":"Ordoubadi","year":"2023","journal-title":"Kona Powder Part. J."},{"key":"10.1016\/j.ejpb.2024.114507_b0050","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.3390\/pharmaceutics15071847","article-title":"Performance testing of a homemade aerosol generator for pulmonary administration of dry powder formulations to mice","volume":"15","author":"Heida","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2024.114507_b0055","doi-asserted-by":"crossref","unstructured":"A.C.-A. Zwygart, C. Medaglia, Y. Zhu, E.B. Tarbet, W. Jonna, C. Fage, D. Le Roy, T. Roger, S. Constant, S. Huang, F. Stellacci, P.J. Silva, C. Tapparel, Development of broad-spectrum \u03b2-cyclodextrins-based nanomaterials against influenza viruses, BioRxiv (2024) 2024.03.05.583334, doi: 10.1101\/2024.03.05.583334.","DOI":"10.1101\/2024.03.05.583334"},{"key":"10.1016\/j.ejpb.2024.114507_b0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejpb.2015.01.012","article-title":"The Cyclops for pulmonary delivery of aminoglycosides; a new member of the TwincerTM family","volume":"90","author":"Hoppentocht","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2024.114507_b0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejps.2005.11.013","article-title":"Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer\u00ae) for high powder doses","volume":"28","author":"de Boer","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"year":"2012","series-title":"Handboek Proefdierkunde","author":"Zutphen","key":"10.1016\/j.ejpb.2024.114507_b0070"},{"key":"10.1016\/j.ejpb.2024.114507_b0075","doi-asserted-by":"crossref","first-page":"L833","DOI":"10.1152\/ajplung.00173.2001","article-title":"Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia","volume":"282","author":"Southam","year":"2002","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ejpb.2024.114507_b0080","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.xphs.2022.01.033","article-title":"Intradermal administration of influenza vaccine with trehalose and pullulan-based dissolving microneedle arrays","volume":"111","author":"Tian","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2024.114507_b0085","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jconrel.2021.06.045","article-title":"Trileucine as a dispersibility enhancer of spray-dried inhalable microparticles","volume":"336","author":"Ordoubadi","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114507_b0090","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jps.21078","article-title":"Trileucine improves aerosol performance and stability of spray-dried powders for inhalation","volume":"97","author":"Lechuga-Ballesteros","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2024.114507_b0095","doi-asserted-by":"crossref","first-page":"e38214","DOI":"10.1371\/journal.pone.0038214","article-title":"Interleukin-6 Is a potential biomarker for severe pandemic H1N1 influenza A infection","volume":"7","author":"Paquette","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2024.114507_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-022-07321-6","article-title":"Interleukin-6 and granulocyte colony-stimulating factor as predictors of the prognosis of influenza-associated pneumonia","volume":"22","author":"Zhang","year":"2022","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ejpb.2024.114507_b0105","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/mi.2012.2","article-title":"Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung","volume":"5","author":"Dienz","year":"2012","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ejpb.2024.114507_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000006","article-title":"Interleukin-6 is crucial for recall of influenza-specific memory CD4 T cells","volume":"4","author":"Longhi","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejpb.2024.114507_b0115","doi-asserted-by":"crossref","first-page":"43829","DOI":"10.1038\/srep43829","article-title":"IL-6 ameliorates acute lung injury in influenza virus infection","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2024.114507_b0120","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41392-021-00679-0","article-title":"The signal pathways and treatment of cytokine storm in COVID-19","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ejpb.2024.114507_b0125","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jaci.2020.07.001","article-title":"The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection","volume":"146","author":"Copaescu","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejpb.2024.114507_b0130","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3390\/v13071362","article-title":"The mechanism behind influenza virus cytokine storm","volume":"13","author":"Gu","year":"2021","journal-title":"Viruses"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124003333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124003333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T19:07:56Z","timestamp":1729710476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641124003333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":26,"alternative-id":["S0939641124003333"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114507","relation":{},"ISSN":["0939-6411"],"issn-type":[{"type":"print","value":"0939-6411"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of influenza virus infection in mice by pulmonary administration of a spray dried antiviral drug","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114507"}}